Isochromosome +i(3)(q10) in a new case of persistent polyclonal B-cell lymphocytosis (PPBL)

A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors.

medRxiv : the preprint server for health sciences·2025

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome.

Thrombosis research·2021

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

Leukemia·2020

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk.

Leukemia·2020

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.

Leukemia·2019

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

Journal of hematology & oncology·2018

TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

European journal of haematology·2026

Post-Hoc Long-Read Sequencing Links Leukemic Mutation Status to Single-Cell Transcriptomes.

European journal of haematology·2026

Toxicity-Related Treatment Cessation in Newly Diagnosed Multiple Myeloma-Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry.

European journal of haematology·2026

Impact of Vincristine Dose Reduction on Outcomes of Patients With Advanced-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

European journal of haematology·2026

Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance.

European journal of haematology·2026

Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany-A Multi-Center Analysis.

European journal of haematology·2026

Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patients.

Frontiers in immunology·2026

CNS Tuberculoma in a Patient of Acute Lymphoblastic Leukemia: A Rare Case Report.

International journal of hematology-oncology and stem cell research·2026

AuPt bimetallic nanocatalyst-amplified luminol-dissolved oxygen electrochemiluminescence for interferon-γ immunosensing.

Frontiers in chemistry·2026

Mucosal regulatory and effector T-cell imbalance in CVID-associated enteropathy.

Frontiers in immunology·2026

Phosphoregulation of interleukin-1 receptor-associated kinase 1 in inflammatory signaling.

Frontiers in immunology·2026

What a negative trial does not tell us: Bayesian reanalysis of the enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients randomized clinical trial.

Clinical nutrition ESPEN·2026

Related Experiment Videos

Isochromosome +i(3)(q10) in a new case of persistent polyclonal B-cell lymphocytosis (PPBL)

Related Concept Videos

A first-in-human, Phase 1/2a, open-label study of SQ3370, a first-in-class doxorubicin-based click chemistry therapeutic, in patients with advanced solid tumors.

Massive intrasplenic arterial thrombosis in a patient with chronic ITP during the development of an Evans syndrome.

Therapy-related myelodysplastic syndromes deserve specific diagnostic sub-classification and risk-stratification-an approach to classification of patients with t-MDS.

miR-146a rs2431697 identifies myeloproliferative neoplasm patients with higher secondary myelofibrosis progression risk.

European recommendations and quality assurance for cytogenomic analysis of haematological neoplasms.

Frequency and clinical impact of CDKN2A/ARF/CDKN2B gene deletions as assessed by in-depth genetic analyses in adult T cell acute lymphoblastic leukemia.

TP53-Altered Aggressive Large B-Cell Lymphoma (LBCL) Outcomes by Treatment Modality: A Multicenter Cohort From 14 US Centers.

Post-Hoc Long-Read Sequencing Links Leukemic Mutation Status to Single-Cell Transcriptomes.

Toxicity-Related Treatment Cessation in Newly Diagnosed Multiple Myeloma-Risk Factors and Survival: An Analysis From the APAC and ANZ Myeloma and Related Diseases Registry.

Impact of Vincristine Dose Reduction on Outcomes of Patients With Advanced-Stage Diffuse Large B-Cell Lymphoma Treated With R-CHOP.

Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance.

Transplantation Strategies in Treatment of Primary Plasma Cell Leukemia in Germany-A Multi-Center Analysis.

Diagnostic value of the kappa free light chain index in multiple sclerosis under the 2024 CSF positivity criterion: a multicentre study in oligoclonal band-negative patients.

CNS Tuberculoma in a Patient of Acute Lymphoblastic Leukemia: A Rare Case Report.

AuPt bimetallic nanocatalyst-amplified luminol-dissolved oxygen electrochemiluminescence for interferon-γ immunosensing.

Mucosal regulatory and effector T-cell imbalance in CVID-associated enteropathy.

Phosphoregulation of interleukin-1 receptor-associated kinase 1 in inflammatory signaling.

What a negative trial does not tell us: Bayesian reanalysis of the enteral citrulline supplementation versus placebo on SOFA score on day 7 in mechanically ventilated critically ill patients randomized clinical trial.

Related Experiment Videos

Isochromosome +i(3)(q10) in a new case of persistent polyclonal B-cell lymphocytosis (PPBL)

Related Concept Videos

Related Articles